GR3034862T3 - Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones. - Google Patents

Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.

Info

Publication number
GR3034862T3
GR3034862T3 GR20000402552T GR20000402552T GR3034862T3 GR 3034862 T3 GR3034862 T3 GR 3034862T3 GR 20000402552 T GR20000402552 T GR 20000402552T GR 20000402552 T GR20000402552 T GR 20000402552T GR 3034862 T3 GR3034862 T3 GR 3034862T3
Authority
GR
Greece
Prior art keywords
gallium
pharmaceutical compositions
pyrones
hydroxy
certain
Prior art date
Application number
GR20000402552T
Other languages
English (en)
Inventor
Lawrence Richard Bernstein
Original Assignee
Lawrence Richard Bernstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lawrence Richard Bernstein filed Critical Lawrence Richard Bernstein
Publication of GR3034862T3 publication Critical patent/GR3034862T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20000402552T 1991-11-12 2000-11-15 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones. GR3034862T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002122908A CA2122908C (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
PCT/US1991/008239 WO1993009776A1 (en) 1991-11-12 1991-11-12 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones

Publications (1)

Publication Number Publication Date
GR3034862T3 true GR3034862T3 (en) 2001-02-28

Family

ID=25677246

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402552T GR3034862T3 (en) 1991-11-12 2000-11-15 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones.

Country Status (10)

Country Link
EP (1) EP0612246B1 (el)
JP (1) JP3348849B2 (el)
KR (1) KR100217001B1 (el)
AT (1) ATE195868T1 (el)
CA (1) CA2122908C (el)
DE (1) DE69132392T2 (el)
DK (1) DK0612246T3 (el)
ES (1) ES2151486T3 (el)
GR (1) GR3034862T3 (el)
WO (1) WO1993009776A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
WO2001024799A1 (en) * 1999-10-04 2001-04-12 Bernstein Lawrence R Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses
DE10113185A1 (de) * 2001-03-19 2002-10-24 Faustus Forschungs Cie Zusammensetzung, enthaltend einen Gallium(III)-Komplex und einen therapeutisch wirksamen Platin-Komplex
WO2005058331A1 (en) * 2003-12-17 2005-06-30 Titan Pharmaceuticals, Inc. Use of gallium to treat inflammatory arthritis
JP2012522789A (ja) * 2009-03-30 2012-09-27 ニッキ ファーマ インク． 骨粗鬆症の治療法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
WO1991017751A1 (en) * 1990-05-24 1991-11-28 Fujisawa, Inc. Orally administrable gallium compositions and methods of treatment therewith

Also Published As

Publication number Publication date
EP0612246A4 (en) 1995-04-19
JP3348849B2 (ja) 2002-11-20
DE69132392T2 (de) 2001-06-07
DE69132392D1 (de) 2000-10-05
DK0612246T3 (da) 2000-12-27
KR100217001B1 (ko) 1999-09-01
CA2122908A1 (en) 1993-05-27
ATE195868T1 (de) 2000-09-15
CA2122908C (en) 2004-08-17
ES2151486T3 (es) 2001-01-01
WO1993009776A1 (en) 1993-05-27
JPH07504153A (ja) 1995-05-11
EP0612246A1 (en) 1994-08-31
EP0612246B1 (en) 2000-08-30

Similar Documents

Publication Publication Date Title
BG104727A (en) Pharmaceutical composition of topiramate
KR940703676A (ko) 알렌드로네이트를 사용한 치근막 질환의 치료방법(Treatment of periodontal disease with alendronate)
TW200744673A (en) Improved ibandronate formulations
BR122012014331B8 (pt) formulações farmacêuticas
BG101118A (en) Therapeutical compounds
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
NL990012I1 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
MX16658A (es) Procedimiento para la preparacion de derivados delacido difosfonico producto obtenido y composicion farmaceutica para el tratamiento de desordenes en el metabolismo del calcio que lo incluye.
BR0011867A (pt) Preparação farmacêutica de levodopa/carbidopa/entacapona
CA2065093A1 (en) Remedies for bone diseases
UA29505C2 (uk) Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців
HUT70482A (en) Immunopotentiatory pharmaceutical compositions containing carbonylgroups
TR200101633T2 (tr) Farmasötik bileşim
DE69919533D1 (de) Proteinhaltige arzneimittel
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
DE69002718D1 (de) Medikamente.
PL320687A1 (en) Use of incense for treating alzheimer disease
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
BR9915729A (pt) Amidas Èmega de n-arilsulfonil-aminoácido
EP0612246A4 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES.
FR2500303B1 (el)
IS1801B (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
SE8704436D0 (sv) Anvendning av antisekretoriska substanser for nya indikationer
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
HU896916D0 (en) Process for producing medical preparation for treating toxoplasmosis

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees